Skip to main content
DEINOVE logo

DEINOVE — Investor Relations & Filings

Ticker · ALDEI ISIN · FR0010879056 LEI · 969500BEJSRFER0F2K08 PA Professional, scientific and technical activities
Open in API
Filings indexed 300 across all filing types
Latest filing 2015-12-21 Capital/Financing Update
Country FR France
Listing PA ALDEI

About DEINOVE

https://www.deinove.com

DEINOVE is a biotechnology company that discovers, develops, and produces high-value compounds derived from rare bacteria and microorganisms, often referred to as 'microbial dark matter'. Leveraging a proprietary technology platform, the company harnesses the metabolic potential of extremophilic bacteria, such as Deinococcus, to create innovative solutions. Its primary applications are focused on developing novel bio-based active ingredients, including carotenoids, for the cosmetics sector, and discovering new antibiotics to address the global challenge of antimicrobial resistance.

Recent filings

Filing Released Lang Actions
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Capital/Financing Update Classification · 1% confidence The document is a press release announcing the successful completion of a capital increase ('augmentation de capital') involving the issuance of new shares and the exercise of an extension clause. This directly relates to changes in the company's capital structure and fundraising activities. Based on the definitions, the most appropriate category is 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a simple dividend notice (DIV). The content focuses entirely on the mechanics and success of the share issuance.
2015-12-21 French
Document availability communications / Methods of making prospectuses available
Capital/Financing Update Classification · 1% confidence The document is titled "DEINOVE ANNOUNCES A CAPITAL INCREASE, WITH SHAREHOLDERS' PREFERENTIAL SUBSCRIPTION RIGHTS, OF APPROXIMATELY €9.3M..." and details the terms, pricing, subscription period, and intended use of proceeds for issuing new shares. This clearly describes a financing activity involving the issuance of new equity, which aligns directly with the definition of a Capital/Financing Update (CAP). Although it mentions the approval of a prospectus by the AMF, the primary content is the announcement of the capital raise itself, not the distribution of the final, comprehensive report (like a 10-K or IR). Therefore, CAP is the most appropriate classification.
2015-11-27 English
Communiqués de mise à disposition de documents / Modalités de mise à disposition de prospectus
Capital/Financing Update Classification · 1% confidence The document is a press release announcing the terms and details of a capital increase ('augmentation de capital') involving the issuance of new shares with preferential subscription rights ('droit préférentiel de souscription'). It specifies the price, parity, subscription period, intended use of funds, and commitments from investors. This clearly falls under the category of updates on company fundraising, financing activities, or capital structure changes. The corresponding code is CAP (Capital/Financing Update). The document is substantial and details the financial operation itself, not just announcing that a report is available (ruling 2 does not apply).
2015-11-27 French
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Earnings Release Classification · 1% confidence The document is titled "Communiqué de presse" (Press Release) and announces a specific operational achievement: successfully producing 2G bioethanol in a 300-liter fermenter. It details technical results (7.3% v/v ethanol) and quotes management regarding future steps (scaling up to m³ demonstrators). This format—a brief announcement highlighting key operational or financial milestones, often released outside of mandatory quarterly/annual filings—is characteristic of an Earnings Release (ER) or a general press release. Since it is not a full financial report (10-K or IR), nor a transcript (CT), nor a specific regulatory filing like DIRS or DIV, the most appropriate classification for a press release announcing operational progress and results is Earnings Release (ER), as these often accompany or precede formal earnings reports, or serve as standalone operational updates. Given the content focuses on production success and future commercialization prospects, ER is the best fit among the provided options, although RNS (Regulatory Filings) is a possibility if ER is strictly reserved for quarterly financial summaries. However, ER often covers significant operational achievements that impact future earnings potential. The length (4822 chars) is substantial for a simple RPA, suggesting it contains substantive information rather than just announcing a report. FY 2015
2015-11-19 French
Communicated under the obligation to provide permanent information / Other communications
Environmental & Social Information Classification · 1% confidence The document is a press release dated November 19, 2015, announcing a significant operational milestone: successfully reaching 2G bioethanol pre-industrial scale in a 300-liter fermenter. It details technical results (7.3% v/v ethanol) and future plans (scale-up to cubic meter). This type of announcement, focusing on operational progress, R&D achievements, and future outlook, is characteristic of an Earnings Release (ER) or a general corporate update. Since it is not a full quarterly report (IR) or a formal regulatory filing like a 10-K, and it focuses on performance highlights rather than just a dividend or management change, it best fits the Earnings Release (ER) category, which often includes operational updates alongside financial context, or sometimes falls into the general Regulatory Filings (RNS) if it's purely operational news. Given the focus on production results and progress towards commercialization, ER is the most appropriate fit among the specific options, as it communicates key performance indicators for the period/project. However, since it is not explicitly tied to a quarterly financial period summary, and is more of a technology/operational update, it could also be considered a general Regulatory Filing (RNS). Comparing ER (initial announcement of periodical financial results - key highlights only) vs RNS (general regulatory announcements/fallback), this reads like a major operational highlight announcement, which often accompanies or precedes an ER. Given the lack of explicit quarterly financial figures, RNS is a safer fallback for a significant, non-standard operational announcement. I will classify it as RNS as it is a specific operational announcement that doesn't perfectly match ER (which usually implies financial results) or any other specific category.
2015-11-19 English
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings Classification · 1% confidence The document is a press release announcing that DEINOVE has been granted six new patents in the United States related to its proprietary technology using *Deinococcus* bacteria for biofuels and bio-based chemicals. This type of announcement, focusing on intellectual property protection and strategic assets, does not fit the definitions for standard financial reports (10-K, IR, ER, MRQ) or corporate governance documents (DEF 14A, CGR). It is a specific announcement regarding the company's assets and strategy, which is best categorized as a general regulatory or corporate announcement. Since there is no specific category for 'Patent Grant Announcement,' and it is not a formal financial filing, it falls under the general 'Regulatory Filings' (RNS) category, which serves as a fallback for miscellaneous corporate news that doesn't fit elsewhere, or potentially 'Capital/Financing Update' (CAP) if the patents were directly tied to a financing round, but here they are presented as an IP milestone. Given the focus on IP and strategic assets, RNS is the most appropriate general classification for this type of press release.
2015-11-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.